writing on the wall?, page-12

Holding up exceptionally well.

Really only check this once a week or so, but looks to be solid support at 2c which is no surprise.

PeriCoach set to launch at the Perth conference in the next few weeks.

Anyone notice ISN now at 80c per share. Market cap near on $200M with nil revenue or FDA approval. If that isn't a case for the potential of the PeriCoach device, also being an MHealth product, then I don't know what is.

We are valued at less than 1/20th ISN, yet the market size, end user base, device costing model etc are frightening similar.

As I've said, not about selling the sausage, it is about selling the sizzle. Brokers with deep enough pockets could very well repeat the ISN story with ALT's PeriCoach, just comes down to incentive and selling the right story.

Would be surprised if we didn't hear something back on Brazil and Taiwan burette efforts also this month. Taiwan regulatory approval should almost be complete and I'd imagine a new draft distribution agreement for Brazil being reviewed.